From obesity to diabetes / Juergen Eckel, Karine Clément, editors.
Eckel, Juergen, editor.; Clément, Karine, 1966- editor.
2022
RC628
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
From obesity to diabetes / Juergen Eckel, Karine Clément, editors.
ISBN
9783030999957 (electronic bk.)
3030999955 (electronic bk.)
9783030999940
3030999947
DOI
https://doi.org/10.1007/978-3-030-99995-7
Published
Cham : Springer, [2022]
Copyright
©2022
Language
English
Description
1 online resource (viii, 513 pages).
Item Number
10.1007/978-3-030-99995-7 doi
Call Number
RC628
Dewey Decimal Classification
616.3/98
Summary
Obesity is a major risk factor for the development of type 2 diabetes and its associated complications, a major socio-economic burden for health care systems. The worldwide prevalence of obesity doubled since 1980 and as a consequence the number of patients with diabetes has been continuously rising with more than 450 Mio. people suffering from this disease at the present time. Substantial progress has been made in understanding the molecular pathways leading from excessive fat accumulation to metabolic perturbation and finally diabetes manifestation. This edition of the "Handbook of Experimental Pharmacology" aims to analyze new insight into the pathophysiology of obesity, to decipher the complex links to diabetes and its complications, and to collect most recent information on new strategies for prevention and treatment of obesity and diabetes.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed July 26, 2022).
Added Author
Eckel, Juergen, editor.
Clément, Karine, 1966- editor.
Series
Handbook of experimental pharmacology ; v. 274. 1865-0325
Available in Other Form
Print version: 9783030999940
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Part I Obesity. Epidemiology of Obesity
The Circadian Clock and Obesity
Nutrition and Microbiome
From Obesity to Diabetes: The Role of the Adipose Organ
Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy
The Enteroendocrine System in Obesity
Insights from Studies of White Adipose Tissue Using Single-Cell Approaches
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Obesity, Senescence, and Senolytics
Obesity and Obstructive Sleep Apnea
Part II Diabetes and Complications. Inter-Organ Crosstalk in the Development of Obesity-Associated Insulin Resistance
Islet Inflammation and [beta] Cell Dysfunction in Type 2 Diabetes
NAFLD and NASH: The Metabolically Diseased Liver
Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities
Diabetic Peripheral Neuropathy
Part III Lifestyle Modifications and Future Treatments. Weight Loss Strategies
Physical Activity, Obesity and Weight Loss Maintenance
Bariatric/Metabolic Surgery
Drugs for Treating Obesity
Novel Drugs for Diabetes Therapy
Novel Approaches to Restore Pancreatic Beta-Cell Mass and Function
Precision Medicine and Obesity
Targeting the Enteroendocrine System for Treatment of Obesity.

Browse Subjects

Show more subjects...

Statistics

from
to
Export